Related Experiment Video
Updated: Jul 23, 2026
04:05
Noninvasive EEG Recordings from Freely Moving Piglets
Published on: July 13, 2018
TENA flex: a new concept in disposable incontinence pads
1Park Drive Health Centre, Baldock, Herts.
British Journal of Nursing (Mark Allen Publishing)
|April 12, 2003
Summary
The new TENA flex offers an improved all-in-one belt-style product for managing moderate to heavy adult urinary incontinence. This innovative design simplifies application and ensures proper fit for better user experience.
Area of Science:
- Gerontology
- Urology
- Product Design
Background:
- Adult incontinence product development is advancing.
- Existing products often require separate fixation components.
- Need for improved solutions for moderate to heavy urinary incontinence.
Purpose of the Study:
- Introduce and discuss the features of TENA flex.
- Highlight its advantages as an all-in-one incontinence product.
- Explain its unique measurement and fitting process.
Main Methods:
- Review of TENA flex product design.
- Description of its belt-style all-in-one system.
- Explanation of the new measurement process for selection and fitting.
Main Results:
- TENA flex is an all-in-one belt-style incontinence product.
- It eliminates the need for separate fixation (pad and pant system).
- A distinct measurement process is utilized for optimal selection, fitting, and positioning.
Conclusions:
- TENA flex represents a significant development in adult incontinence management.
- Its design offers a simpler and potentially more effective solution.
- Further discussion on the product's features is warranted.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:23Urinary Bladder
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...